Categories: News

Wingderm Strengthens Presence in Asia at IMCAS Asia 2025

BEIJING, June 10, 2025 /PRNewswire/ — From June 6 to 8, 2025, IMCAS Asia was successfully held in Bangkok, Thailand. As one of the world’s leading medical aesthetic events, IMCAS Asia brought together the latest developments and trends in the Asian medical aesthetic market. Wingderm® once again showcased its innovative medical aesthetic solutions.

- Advertisement -

Focusing on Asia’s Growing Medical Aesthetic Market
The Asian market includes both mature economies, such as China, Japan, and South Korea, as well as rapidly growing Southeast Asian countries. This makes the region a crucial player in the global medical aesthetic industry. IMCAS Asia is not only a platform for sharing knowledge, but also offers Wingderm® a valuable opportunity to better understand practitioner perspectives and stay aligned with market trends, supporting product upgrades and strategic expansion.

- Advertisement -

Tech Meets Trust: Driving Mutual Growth through Innovation
At IMCAS Asia, Wingderm® presented a series of advanced medical aesthetic devices, including Mesoskin for non-invasive delivery, Lasermach for fast and comfortable laser hair removal, and Renuva, a device powered by 1550nm non-ablative fractional laser for skin resurfacing. Our success at the event was thanks to the support of our local distributor in Thailand. We will continue this close partnership for mutual benefit.

- Advertisement -

Next Stop: TAS 2025 in Las Vegas
Driven by technology and innovation, Wingderm® is always looking for new ways to apply our technologies and enhance user experiences. Through industry events, we share our latest advancements and strengthen connections with industry professionals around the world. Wingderm® will be at booth 712 during TAS 2025, held from June 27 to 29 in Las Vegas. Please visit us there!

- Advertisement -

About Wingderm®
Wingderm® since its establishment in 2016, with the aim of “Aesthetics&Technology, Easy to Achieve”, provides leading and reliable intelligent photoelectric medical aesthetic devices, which have been exported to more than 80 countries, with over 25,000 units installed, recognized for safety and effectiveness by experts and beauty seekers.

- Advertisement -

For more information, visit: https://www.wingderm.com

- Advertisement -

 

- Advertisement -

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/wingderm-strengthens-presence-in-asia-at-imcas-asia-2025-302477069.html

- Advertisement -

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

6 hours ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

6 hours ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

6 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

6 hours ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

6 hours ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

6 hours ago